Explore more publications!

Press Releases

Greenwich LifeSciences Provides Global Update on FLAMINGO-01
Vivian Glyck Launches 'The Bad Mom Podcast: Parenting The Anxious Generation'
PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial
Non-Alcoholic Drinks Market Size, Growth Opportunities, Outlook and Company Profiles, 2035
Pawn Expert Josh Stern of Fort Lauderdale, FL Shares Tips for Jewelry Appraisals in HelloNation
Boston Signs and Graphics Launches Custom Channel Letter Signage to Help Local Businesses Increase Visibility and Equity
Thousands of people in Russia lose power due to Ukrainian strikes

Thousands of people in Russia lose power due to Ukrainian strikes

DIEGO ROGGERO, GENERAL MANAGER OF PORTRAIT MILANO, IS THE WINNER OF THE ANNUAL EHMA SUSTAINABILITY AWARD BY DIVERSEY
Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors
Author and Advocate Dana Priyanka Hammond Launches DPH Publishing to Empower Purpose-Driven Writers
OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025
Immutep’s Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense   
DME Service Solutions Names New COO: Chillo Chang to Lead Operations Across Global Hubs
Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update
Kaleo’s AUVI-Q® (epinephrine injection, USP) Selected by Axiom Space to Help Protect Crew from Allergic Emergencies
EnPak LLC Announces ISO 13485:2016 Certification
[Latest] Global Cigar and Cigarillos Market Size/Share Worth USD 120.71 Billion by 2034 at a 8.17% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
Biogen to Advance Investigational Spinal Muscular Atrophy Asset to Registrational Studies Based on Positive Interim Phase 1 Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions